ZBH Crosses Above Average Analyst Target
December 02, 2022 at 07:23 AM EST
In recent trading, shares of Zimmer Biomet Holdings Inc (ZBH) have crossed above the average analyst 12-month target price of $122.50, changing hands for $123.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..